Evonik, one of the world's leading specialty chemicals companies, is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The ...
Evonik Industries AG (Essen, Germany) is making a significant investment to strengthen manufacturing capabilities at its ...
Meets the growing demand for U.S.-based contract development and manufacturing organizations (CDMOs)Further improves capabilities to handle increasing complexity of active pharmaceutical ingredients ...
What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...
Sridevi Khambhampaty, CEO, Shilpa Biologicals Pvt Ltd commented, “The manufacturing of highly potent compounds has been a core pillar of Shilpa’s identity and this ADC drug su ...
After pledging earlier this year to bolster its drug substance capabilities in Central Europe, German chemical company Evonik is turning its attention to the U.S. The company is laying out $100 ...
Throughout 2025, drugmakers of all stripes have collectively poured billions of dollars into U.S. manufacturing investments. Many of those projects have centered on later stages of the production ...
SHANGHAI, June 24, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its MFG17 drug substance ...
Shilpa Biologicals commissions ADC GMP plant in India, offering end-to-end drug substance manufacturing to meet FDA and EMA standards for global partners.
Shilpa Biologicals Ltd, a subsidiary of Shilpa Medicare Ltd announced the commissioning of a state-of-the-art antibody–drug conjugate (ADC) GMP manufacturing facility, purpose-built and designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results